Director and Illumina Funds Disclose 9.6% Stake in Alamar Biosciences Post-IPO
ALMR is trading near its 52-week low of $21.75 (9.4% above the low) on light trading volume (0.4× avg).
Summary
Illumina Innovation Funds and Director Nicholas Naclerio have disclosed a 9.6% beneficial ownership in Alamar Biosciences, Inc. post-IPO, representing a significant stake valued at over $151 million.
Key Events · Ownership and Investor Activity · ALMR
-
Significant Ownership Disclosure
Illumina Innovation Fund II, L.P., Illumina Innovation Fund III, L.P., and Director Nicholas Naclerio collectively reported beneficial ownership of 6,363,612 shares, representing 9.6% of Alamar Biosciences' common stock.
-
Post-IPO Stake
This substantial ownership was established following the company's initial public offering, with shares acquired through the conversion of preferred stock and convertible notes, and a direct purchase in the IPO.
-
Director Involvement
Nicholas Naclerio, a director of Alamar Biosciences, Inc., is the sole managing member of the general partners for both Illumina Innovation Funds, linking the significant institutional stake directly to an insider.
-
Lock-Up Agreement
The reporting persons are subject to a 180-day lock-up agreement, restricting the sale or transfer of their shares for that period, which provides near-term stability.
Analysis · ALMR · Industrial Applications And Services
This initial Schedule 13D filing reveals that Illumina Innovation Funds and Director Nicholas Naclerio collectively hold a substantial 9.6% beneficial ownership in Alamar Biosciences, Inc. following its recent IPO. The significant stake, valued at over $151 million, signals strong conviction from a key pre-IPO investor and an insider. The reporting persons are also subject to a 180-day lock-up agreement, providing near-term stability for the stock. This disclosure comes as the company's stock trades near its 52-week high, reflecting positive market reception post-IPO.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALMR was trading at $23.79 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $21.75 to $25.03. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.